Tasimelteon — Blue Cross Blue Shield Of Kansas
4 indications indexed for this drug.
- Nighttime Sleep Disturbances Associated With Smith Magenis SView coverage criteria
- Non 24 Hour Sleep Wake Disorder Non 24 SwdView coverage criteria
- Other Fda Labeled Indications For The Requested Agent And RoView coverage criteria
- Other Indications Supported In Compendia For The Requested AView coverage criteria